These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1089756)

  • 21. Serratia marcescens in a general hospital.
    Ball AP; McGhie D; Geddes AM
    Q J Med; 1977 Jan; 46(181):63-71. PubMed ID: 325592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serratia marcescens isolated in 2005 from clinical specimens from patients with diminished immunity.
    Młynarczyk A; Młynarczyk G; Pupek J; Bilewska A; Kawecki D; Łuczak M; Gozdowska J; Durlik M; Paczek L; Chmura A; Rowińnski W
    Transplant Proc; 2007 Nov; 39(9):2879-82. PubMed ID: 18022007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations.
    Zhao WH; Hu ZQ; Chen G; Ito R; Shimamura T
    Chemotherapy; 2008; 54(1):31-7. PubMed ID: 18063864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survey of modifying enzymes and plasmids in amikacin-resistant Serratia marcescens.
    Katoh-Kanno R; Kimura M; Ikeda T; Kimura S
    Microbiol Immunol; 1986; 30(6):509-19. PubMed ID: 3528769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New inactivating enzyme of aminoglycoside antibiotics produced by genes on R-plasmid of Serratia spp. and nosocomial infection].
    Hayashi I; Onuma K; Morohoshi T
    Kansenshogaku Zasshi; 1991 Apr; 65(4):465-71. PubMed ID: 2071963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Partial characterization of Serratia marcescens nosocomial strains.
    Coria-Jiménez VR; Villa-Tanaka L; Ortíz-Torres C
    Arch Invest Med (Mex); 1991; 22(3-4):273-8. PubMed ID: 1844112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smaqnr, a new chromosome-encoded quinolone resistance determinant in Serratia marcescens.
    Velasco C; Rodríguez-Martínez JM; Briales A; Díaz de Alba P; Calvo J; Pascual A
    J Antimicrob Chemother; 2010 Feb; 65(2):239-42. PubMed ID: 19942618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serratia marcescens: use of detailed characterization of strains to evaluate an increase of isolates in an intensive care unit.
    Cardos SF; Florman AL; Simberkoff MS; Lanier L
    Am J Med Sci; 1973 Dec; 266(6):447-52. PubMed ID: 4590096
    [No Abstract]   [Full Text] [Related]  

  • 29. Endemic Serratia marcescens in the Veterans Administration Hospital in Pittsburgh, Pa., 1971--1976.
    Brown A; Davis L; Yee RB; Postic B
    Health Lab Sci; 1978 Jul; 15(3):159-67. PubMed ID: 359506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New R-plasmids in strains of Serratia marcescens with multiple drug resistance].
    Kurnosova LM; Domaradskiĭ IV; Morshchakova GN; Kruglova AA; Smolianskaia AZ
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):3-6. PubMed ID: 3521159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Epidemiological evaluation of Serratia marcescens isolates in one Japanese hospital during the two years from April 1997 to March 1999].
    Marumo K; Nakamura Y; Togashi M
    Rinsho Byori; 2000 Oct; 48(10):960-5. PubMed ID: 11215111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic susceptibility of clinical isolates of Serratia marcescens compared with sensitivity to group A (phage tail) bacteriocins.
    Traub WH
    Chemotherapy; 1978; 24(5):301-13. PubMed ID: 352637
    [No Abstract]   [Full Text] [Related]  

  • 33. Characterization of imipenem-resistant Serratia marcescens producing IMP-type and TEM-type beta-lactamases encoded on a single plasmid.
    Zhao WH; Hu ZQ; Chen G; Matsushita K; Fukuchi K; Shimamura T
    Microbiol Res; 2007; 162(1):46-52. PubMed ID: 16875810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outbreak of multidrug-resistant Serratia marcescens infection in a neonatal intensive care unit.
    Maragakis LL; Winkler A; Tucker MG; Cosgrove SE; Ross T; Lawson E; Carroll KC; Perl TM
    Infect Control Hosp Epidemiol; 2008 May; 29(5):418-23. PubMed ID: 18419363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromosomal origin of acetyltransferase AAC(6') specifying amikacin resistance in Serratia marcescens.
    Gómez-Lus R; Rivera MJ; Bobey D; Martín C; Navarro M
    Microbiologia; 1987 Oct; 3(3):185-94. PubMed ID: 3077328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nosocomial outbreak of ceftazidime-resistant Serratia marcescens strains that produce a chromosomal AmpC variant with N235K substitution.
    Yatsuyanagi J; Saito S; Konno T; Harata S; Suzuki N; Kato J; Amano K
    Jpn J Infect Dis; 2006 Jun; 59(3):153-9. PubMed ID: 16785694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An outbreak of multidrug-resistant Serratia marcescens: the importance of continuous monitoring of nosocomial infections.
    Šiširak M; Hukić M
    Acta Med Acad; 2013; 42(1):25-31. PubMed ID: 23735063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serratia marcescens bacteremia at a medical center in southern Taiwan: high prevalence of cefotaxime resistance.
    Shih HI; Lee HC; Lee NY; Chang CM; Wu CJ; Wang LR; Ko NY; Ko WC
    J Microbiol Immunol Infect; 2005 Oct; 38(5):350-7. PubMed ID: 16211144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and characterization of extended spectrum β-lactamases in Klebsiella-Enterobacter-Serratia group bacteria, in Algeria.
    Nedjai S; Barguigua A; Djahmi N; Jamali L; Zerouali K; Dekhil M; Timinouni M
    Med Mal Infect; 2012 Jan; 42(1):20-9. PubMed ID: 22056377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the Serratia marcescens SdeCDE multidrug efflux pump studied via gene knockout mutagenesis.
    Begic S; Worobec EA
    Can J Microbiol; 2008 May; 54(5):411-6. PubMed ID: 18449226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.